People · Operator
Named in public records as an officer, director or promoter · active 2024–2025 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| GelMEDIX, Inc. | — | Biotechnology | Series A | $9.9M | $1.6M | 2024 |
Max Cotler at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Max Cotler on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Michael Cima | 1 | 4 |
| Jeffrey Behrens | 1 | 3 |
| PARINAZ MOTAMEDY | 1 | 3 |
| Reza Dana | 1 | 3 |
| Nasim Annabi | 1 | 1 |
| Arthur Driscoll | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.